Tyr Pharma Stock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tyr pharma stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tyr Pharma Stock Today - Breaking & Trending Today

aTyr Pharma (NASDAQ:LIFE) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

aTyr Pharma (NASDAQ:LIFE) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Atyr Pharma Inc , Royal Bank , Tyr Pharma , Get Free Report , Yahoo Finance , Tyr Pharma Stock , Tyr Pharma Daily ,

Short Interest in aTyr Pharma, Inc. (NASDAQ:LIFE) Rises By 167.4%

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […] ....

United States , Tyr Pharma Company Profile , Da Davidson , Charles Schwab Investment Management Inc , Virtu Financial , Royal Bank , Atyr Pharma Inc , A Davidson , Tyr Pharma , Get Free Report , Tyr Pharma Stock , Fire Capital , Charles Schwab Investment Management , Schwab Investment Management , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

Short Interest in aTyr Pharma, Inc. (NASDAQ:LIFE) Rises By 167.4%

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […] ....

United States , Royal Bank , Atyr Pharma Inc , A Davidson , Virtu Financial , Charles Schwab Investment Management Inc , Tyr Pharma Company Profile , Da Davidson , Tyr Pharma , Get Free Report , Tyr Pharma Stock , Fire Capital , Charles Schwab Investment Management , Schwab Investment Management , Tyr Pharma Company , Tyr Pharma Daily ,

aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $20.75 Consensus Target Price from Analysts

aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $20.75 Consensus Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Virtu Financial , Charles Schwab Investment Management Inc , Capital Partners , Atyr Pharma Inc , A Davidson , Tyr Pharma , Get Free Report , Fire Capital , Schwab Investment Management , Tyr Pharma Stock , Get Free , Tyr Pharma Daily ,

aTyr Pharma (NASDAQ:LIFE) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reissued their buy rating on shares of aTyr Pharma (NASDAQ:LIFE – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a $35.00 price target on the biotechnology company’s stock. Separately, StockNews.com lowered aTyr Pharma from a hold rating to a sell rating in a research […] ....

United States , Blackrock Inc , Alyeska Investment Group , Tyr Pharma Company Profile , Vanguard Group Inc , Samsara Biocapital , Atyr Pharma Inc , Tyr Pharma , Free Report , Moderate Buy , Tyr Pharma Stock , Tyr Pharma Company , Get Free Report , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Reiterated Rating , Hc Wainwright ,